Potassium Chloride In Sodium Chloride Injection, Solution
NDC Package 0338-0691-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Potassium Chloride In Sodium Chloride (potassium chloride and sodium chloride) injection is potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes. This formulation utilizes a injection, solution delivery system. Marketed by Baxter Healthcare Company, this product is identified by NDC 0338-0691 and is authorized under FDA application NDA017648.

Identification & Billing

NDC Package Code
0338-0691-04
Package Description
14 BAG in 1 CARTON / 1000 mL in 1 BAG
Product Code
0338-0691
11-Digit Billing Format
00338069104
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 237367 - potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection
  • RxCUI: 237367 - 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection
  • RxCUI: 237367 - 1000 ML K+ Chloride 0.04 MEQ/ML / NaCl 9 MG/ML Injection
  • RxCUI: 237367 - 1000 ML Pot Chloride 0.04 MEQ/ML / NaCl 9 MG/ML Injection
  • RxCUI: 237367 - potassium chloride 40 MEQ / sodium chloride 0.9 % per 1000 ML Injection

Clinical Specifications

Proprietary Name
Potassium Chloride In Sodium Chloride
Non-Proprietary Name
Potassium Chloride And Sodium Chloride
Substance Name
Potassium Chloride; Sodium Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes.

Regulatory & Marketing

Labeler Name
Baxter Healthcare Company
Product Type
Human Prescription Drug
FDA Application #
NDA017648
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-02-1979
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J3480
Source: ASP
Inj potassium chloride
HCPCS Dosage 2 MEQ
Units / Pkg 140

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0338-0691-04 identifies a specific commercial package of 14 bag in 1 carton / 1000 ml in 1 bag of Potassium Chloride In Sodium Chloride, a human prescription drug labeled by Baxter Healthcare Company. This injection, solution is formulated for intravenous use and contains potassium chloride; sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Baxter Healthcare Company on February 02, 1979. The current certification is valid through December 31, 2026.

How is this Baxter Healthcare Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00338069104. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0338-0691-04
11-Digit CMS (5-4-2)
00338-0691-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.